N-[(3-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-fluorophenyl)methyl]-2-(trifluoromethyl)-1,8-naphthyridine-3-carboxamide
C51H39Br2F4N9O3 — CID 161411118
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(3-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-fluorophenyl)methyl]-2-(trifluoromethyl)-1,8-naphthyridine-3-carboxamide
N-[(3-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-fluorophenyl)methyl]-2-(trifluoromethyl)-1,8-naphthyridine-3-carboxamide (PubChem CID 161411118) has the molecular formula C51H39Br2F4N9O3 and a molecular weight of 1061.73 g/mol. Its IUPAC name is N-[(3-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-fluorophenyl)methyl]-2-(trifluoromethyl)-1,8-naphthyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[(3-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-fluorophenyl)methyl]-2-(trifluoromethyl)-1,8-naphthyridine-3-carboxamide |
|---|---|
| PubChem CID | 161411118 |
| Molecular Formula | C51H39Br2F4N9O3 |
| Molecular Weight | 1061.73 g/mol |
| Exact Mass | 1059.15 |
| IUPAC Name | N-[(3-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-bromophenyl)methyl]-2-methyl-1,8-naphthyridine-3-carboxamide;N-[(4-fluorophenyl)methyl]-2-(trifluoromethyl)-1,8-naphthyridine-3-carboxamide |
| SMILES | Cc1nc2ncccc2cc1C(=O)NCc1ccc(Br)cc1.Cc1nc2ncccc2cc1C(=O)NCc1cccc(Br)c1.O=C(NCc1ccc(F)cc1)c1cc2cccnc2nc1C(F)(F)F |
| InChI | InChI=1S/2C17H14BrN3O.C17H11F4N3O/c1-11-15(9-13-5-3-7-19-16(13)21-11)17(22)20-10-12-4-2-6-14(18)8-12;1-11-15(9-13-3-2-8-19-16(13)21-11)17(22)20-10-12-4-6-14(18)7-5-12;18-12-5-3-10(4-6-12)9-23-16(25)13-8-11-2-1-7-22-15(11)24-14(13)17(19,20)21/h2*2-9H,10H2,1H3,(H,20,22);1-8H,9H2,(H,23,25) |
| InChIKey | VVMDIUQATVURAW-UHFFFAOYSA-N |
| XLogP | 10.98 |
| TPSA | 164.64 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 69 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1061.73 |
| LogP ≤ 5 | 10.98 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161411118 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.